Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study
Study Details
Study Description
Brief Summary
Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10.
The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Studies performed on American and Chinese populations have shown positive results. These studies need confirmation in different populations. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10. The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Red rice yeast group Red rice yeast based product will be provided under the brand name Molval Fort, one pill a day, for 8 weeks, for a moderate intensity treatment equivalent according the American College of Cardiology/American Heart Association (ACC/AHA) guidelines definitions |
Drug: Red Rice Yeast Extract
adults requiring moderate intensity treatment will be provided red rice yeast extracts or statins, depending on the randomization; followed for compliance and adverse effects check, and reevaluated in a final visit with blood test after 8 weeks
|
Active Comparator: Statin group Statin choice is done at the discretion of the treating physician for a moderate intensity treatment equivalent according the American College of Cardiology/American Heart Association (ACC/AHA) guidelines definitions, for 8 weeks |
Drug: Statin
Statin choice is done at the discretion of the treating physician for a moderate intensity treatment equivalent according the American College of Cardiology/American Heart Association (ACC/AHA) guidelines definitions, for 8 weeks
|
Outcome Measures
Primary Outcome Measures
- LDL reduction [eight weeks]
after an eight week treatment, cholesterol LDL levels' reduction is compared in the two groups
Secondary Outcome Measures
- incidence of side effects [eight weeks]
after eight weeks of treatment, the incidence of side effects is studied among the red rice yeast group
Other Outcome Measures
- physician and patient satisfaction [eight weeks]
physician and patient satisfaction will be evaluated by a single question questionnaire: Were you satisfied by the treatment?
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Adult patient (>18 years)
-
Indication to mild or moderate statin based on AHA 2013 guidelines
-
Treatment naïve
Exclusion Criteria:
-
Allergy to rice
-
Renal or hepatic terminal disease
-
Any contra indication to statin treatment
-
Pregnancy wish during study period
-
Familial hypercholesterolemia
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Saint Anthony Primary Care Center | Jdeide | Lebanon |
Sponsors and Collaborators
- Saint-Joseph University
Investigators
- Principal Investigator: Marouan Zoghbi, Hôtel Dieu de France Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RRY2018